Olmesartan medoxomil
NDC 72603-951, Olmesartan medoxomil, tablet, from NorthStar RxLLC.
- Product NDC
- 72603-951
- Status
- Listed
- Labeler
- NorthStar RxLLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204814
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72603-951 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OLMESARTAN MEDOXOMIL20 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72603-951-01 | 72603095101 | 30 TABLET in 1 BOTTLE (72603-951-01) |
| 72603-951-02 | 72603095102 | 90 TABLET in 1 BOTTLE (72603-951-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/812d2d57-14d6-48a9-9687-85c2d125197e
Use it
Look up 72603-951 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72603-951 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72603-951. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.